HUE058308T2 - Vérlemezkepellet-lizátum neurológiai rendellenességek kezelésében való felhasználásra - Google Patents

Vérlemezkepellet-lizátum neurológiai rendellenességek kezelésében való felhasználásra

Info

Publication number
HUE058308T2
HUE058308T2 HUE17712161A HUE17712161A HUE058308T2 HU E058308 T2 HUE058308 T2 HU E058308T2 HU E17712161 A HUE17712161 A HU E17712161A HU E17712161 A HUE17712161 A HU E17712161A HU E058308 T2 HUE058308 T2 HU E058308T2
Authority
HU
Hungary
Prior art keywords
neurological disorders
treating neurological
platelet pellet
pellet lysate
lysate
Prior art date
Application number
HUE17712161A
Other languages
English (en)
Inventor
David Devos
Thierry Burnouf
Jean-Christophe Devedjian
Ming-Li Chou
Original Assignee
Centre Hospitalier Regional Et Univ De Lille
Univ Lille
Univ Du Littoral Cote Dopale
Inst Nat Sante Rech Med
Univ Taipei Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier Regional Et Univ De Lille, Univ Lille, Univ Du Littoral Cote Dopale, Inst Nat Sante Rech Med, Univ Taipei Medical filed Critical Centre Hospitalier Regional Et Univ De Lille
Publication of HUE058308T2 publication Critical patent/HUE058308T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HUE17712161A 2016-03-23 2017-03-23 Vérlemezkepellet-lizátum neurológiai rendellenességek kezelésében való felhasználásra HUE058308T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16305332 2016-03-23

Publications (1)

Publication Number Publication Date
HUE058308T2 true HUE058308T2 (hu) 2022-07-28

Family

ID=55646508

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17712161A HUE058308T2 (hu) 2016-03-23 2017-03-23 Vérlemezkepellet-lizátum neurológiai rendellenességek kezelésében való felhasználásra

Country Status (14)

Country Link
US (1) US20190099448A1 (hu)
EP (1) EP3432895B1 (hu)
JP (2) JP7189123B2 (hu)
CN (1) CN109310711B (hu)
AU (1) AU2017238476B2 (hu)
CA (1) CA3018637A1 (hu)
DK (1) DK3432895T3 (hu)
ES (1) ES2908723T3 (hu)
HU (1) HUE058308T2 (hu)
IL (1) IL261981B (hu)
PL (1) PL3432895T3 (hu)
PT (1) PT3432895T (hu)
TW (1) TWI744300B (hu)
WO (1) WO2017162830A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途
FR3077824B1 (fr) 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
FR3077823B1 (fr) 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
EP3881858A1 (en) * 2020-03-20 2021-09-22 Rok Pangersic Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect
EP4190892A1 (en) * 2020-07-31 2023-06-07 Rainbow Inc. Platelet lysate derived from autologous platelets
JP7025070B1 (ja) 2021-05-14 2022-02-24 セルソース株式会社 血液由来成長因子含有組成物及びその調製方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1124144A (zh) * 1994-12-05 1996-06-12 中国药科大学 一种治疗心脑血管神经系统病及肿瘤的全蝎制剂及其制备方法
NZ502820A (en) * 1997-08-29 2002-10-25 Vertex Pharma Heteroaryl or aryl substituted carboxylic acid or carboxamide derivatives optionally substituted with a sulphonamido group
US20090297485A1 (en) * 2008-05-28 2009-12-03 Allan Mishra Compositions and methods for treating psychiatric and neurodegenerative disorders
TW201119659A (en) * 2009-12-11 2011-06-16 Univ Taipei Medical Composition for treating articular defect and method thereof
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
CN101914561B (zh) * 2010-07-13 2013-04-17 广东药学院 一种具有抗菌和修复功能的融合蛋白及其生产方法和应用
TWI535848B (zh) * 2011-02-22 2016-06-01 臺北醫學大學 包含眼窩脂肪衍生之幹細胞（ｏｆｓｃ）之細胞群及彼等之分離與應用
EP2505292A1 (en) * 2011-03-30 2012-10-03 Universitätsklinikum Freiburg Method for modifying an electrically non-conductive workpiece via spark erosion
TW201319084A (zh) * 2011-11-15 2013-05-16 Human Protein Process Sciences Sarl 血小板源腦源性神經滋養因子濃厚液及其製備方法
KR101278204B1 (ko) * 2011-12-22 2013-06-27 경북대학교 산학협력단 다중 약물전달계를 갖는 생체의료용 금속합금 재료의 제조방법
WO2014027363A1 (en) * 2012-08-17 2014-02-20 Kasiak Research Pvt. Ltd. A growth factor concentrate for treating hair loss
WO2014027360A1 (en) * 2012-08-17 2014-02-20 Kasiak Research Pvt. Ltd. A growth factor concentrate for treating facial wrinkles
WO2014027361A1 (en) * 2012-08-17 2014-02-20 Kasiak Research Pvt. Ltd. A growth factor concentrate for treating periorbital hyperpigmentation
WO2014027359A1 (en) * 2012-08-17 2014-02-20 Kasiak Research Pvt. Ltd. A growth factor concentrate for treating tendinopathies
PT2938597T (pt) * 2012-12-27 2016-12-09 Université De Lille 2 Droit Et Santé Sais sulfato de n-(3-(4-(3-(isobutilamino)propil)-piperazin-1-il)propil)-1h-benzo[d]imidazol-2-amina, sua preparação e sua utilização
EP2767511B1 (en) * 2013-02-19 2016-12-14 Grupo Antolín Ingeniería, S.A. Process for obtaining a uniform dispersion of graphene platelets in a liquid
EP2968315B1 (en) * 2013-03-15 2020-06-03 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
EP3154934B1 (en) * 2014-06-16 2021-04-14 Université de Lille Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
CN104856892B (zh) * 2014-11-14 2018-06-15 广州远想生物科技有限公司 一种富含生长因子的化妆品或护肤品制剂及其制备方法
EP3070071A1 (en) * 2015-03-16 2016-09-21 Construction Research & Technology GmbH A process for forming roughened micron size anisotropic platelets
US10017476B2 (en) * 2015-03-16 2018-07-10 Inserm (Institut National De La Sante Et De La Recherche Medicale) 1,4-bis(3-aminopropyl)piperazine derivative and its use
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途
EP3254684B1 (en) * 2016-06-08 2019-10-23 Lysatpharma GmbH Human platelet lysate or fraction enriched in human platelet-derived extracellular vesicles, for use in medicine
CN110891582A (zh) * 2017-06-16 2020-03-17 里尔大学中心医院 制备混合人血小板裂解液的方法、混合人血小板裂解液及其用于治疗神经系统疾病的用途
AU2018309085B2 (en) * 2017-08-03 2022-12-08 Galectin Sciences, Llc Compounds for the prevention and treatment of medical disorders and uses thereof
TW201914595A (zh) * 2017-09-27 2019-04-16 法國里爾中央醫學中心 製備血小板裂解物組分的方法、血小板裂解物組分及其用於治療中樞神經系統疾病的用途
US20200323964A1 (en) * 2017-10-16 2020-10-15 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of mrna
BR112020013714A2 (pt) * 2017-12-15 2020-12-01 The Australian National University compostos para tratamento e prevenção de patologias mediadas por histona extracelular
FR3077823B1 (fr) * 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
FR3077824B1 (fr) * 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
CN112424359A (zh) * 2018-05-15 2021-02-26 沃雅戈治疗公司 用于治疗帕金森氏病的组合物和方法
KR102308484B1 (ko) * 2019-10-02 2021-10-06 단국대학교 천안캠퍼스 산학협력단 3d 프린팅을 이용한 다공성 고분자 인공 지지체 및 이의 제조방법

Also Published As

Publication number Publication date
PL3432895T3 (pl) 2022-04-04
ES2908723T3 (es) 2022-05-03
US20190099448A1 (en) 2019-04-04
CA3018637A1 (en) 2017-09-28
IL261981A (en) 2018-10-31
EP3432895A1 (en) 2019-01-30
AU2017238476B2 (en) 2022-02-24
JP2022180609A (ja) 2022-12-06
TW201800581A (zh) 2018-01-01
JP2019513154A (ja) 2019-05-23
AU2017238476A1 (en) 2018-10-11
DK3432895T3 (da) 2022-03-21
CN109310711B (zh) 2022-06-10
WO2017162830A1 (en) 2017-09-28
TWI744300B (zh) 2021-11-01
EP3432895B1 (en) 2021-12-29
CN109310711A (zh) 2019-02-05
JP7189123B2 (ja) 2022-12-13
PT3432895T (pt) 2022-03-21
IL261981B (en) 2022-04-01

Similar Documents

Publication Publication Date Title
HK1252741A1 (zh) 用於治療神經疾病的組合物和方法
IL291533A (en) Compounds and preparations including them for the treatment of diseases of the central nervous system
IL267082A (en) Systems and methods for the treatment of neurological disorders
HK1259336A1 (zh) 用於治療骨髓增生性病症的方法
HUE051488T2 (hu) Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
IL279308A (en) Methods for the treatment of heptidine-mediated disorders
HK1256036A1 (zh) 治療骨髓增生性障礙的方法
HUE049014T2 (hu) Készítmények és módszerek a központi idegrendszer rendellenességeinek kezelésére
HUE058308T2 (hu) Vérlemezkepellet-lizátum neurológiai rendellenességek kezelésében való felhasználásra
PT3119911T (pt) Compostos para uso no tratamento da doença de alzheimer em pacientes apoe4+/+
FI3551189T3 (fi) Alpratsolaami epilepsian hoitoon
PL3160464T3 (pl) 6-hydroksybuspiron do stosowania w leczeniu zaburzeń ruchowych
PL3291691T3 (pl) Wykorzystanie azotanów w leczeniu poporodowej dysgalakcji u ssaków jednożołądkowych
PT3420084T (pt) Nova abordagem para tratamento de disfunções inflamatórias
GB201602011D0 (en) Treating skin disorders